Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001508474 | SCV001714651 | uncertain significance | not provided | 2020-08-05 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002495780 | SCV002789816 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2022-04-17 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001508474 | SCV003825629 | uncertain significance | not provided | 2022-07-21 | criteria provided, single submitter | clinical testing |